News
Peter DeYoung, CEO at Piramal Pharma Limited, explains how Piramal is meeting the growing demand for integrated biologics ...
In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) ...
Pharmaceutical Technology® spoke with Martin Meeson, CEO of Axplora, about the role contract development and manufacturing ...
Teva’s investigational monoclonal antibody, TEV-53408, has been designed for use in adults with celiac disease, for which a ...
Leveraging computerized maintenance management systems software can enhance efficiency, improve quality control, ensure ...
Global scale-up requires developing replicable processes that work the same no matter where they are performed. This can be ...
In discussions at INTERPHEX 2025, company representatives seized upon several common themes, most notably safety, ...
MHRA approves Loba Biotech to manufacture Pegasys API, enabling pharma& to strengthen UK supply and ensure continued access for eligible patients.
Christy Eatmon of Thermo Fisher Scientific reviewed her company’s experience at CPHI Americas 2025 and discussed recent industry trends that are driving strategic partnerships.
Inobrodib is being developed as a first-in-class oral cancer drug that the company says will be able to treat not only ...
Dave Wood, CEO at Experic, discusses how decades of expertise with advanced technologies helps pharmaceutical and biotech ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results